The Protein Farnesyltransferase Inhibitor Tipifarnib as a new Lead for the Development of Drugs against Chagas Disease

Lignende værker

• Second Generation Analogs of the Cancer Drug Clinical Candidate Tipifarnib for Anti-Chagas Disease Drug Discovery
  af: Kraus, James M., et al.
  Udgivet: (2010)
• Rational Modification of a Candidate Cancer Drug for Use Against Chagas Disease
  af: Kraus, James M, et al.
  Udgivet: (2009)
• Pharmacological Characterization, Structural Studies, and In Vivo Activities of Anti-Chagas Disease Lead Compounds Derived from Tipifarnib
  af: Buckner, Frederick S., et al.
  Udgivet: (2012)
• Bioactivity of Farnesyltransferase Inhibitors Against Entamoeba histolytica and Schistosoma mansoni
  af: Probst, Alexandra, et al.
  Udgivet: (2019)
• Efficacy, Pharmacokinetics, and Metabolism of Tetrahydroquinoline Inhibitors of Plasmodium falciparum Protein Farnesyltransferase
  af: Van Voorhis, Wesley C., et al.
  Udgivet: (2007)